Fifth Third Bancorp Vir Biotechnology, Inc. Transaction History

Fifth Third Bancorp

  • $27.3 Billion
  • Q3 2024

A detailed history of Fifth Third Bancorp transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Fifth Third Bancorp holds 1,925 shares of VIR stock, worth $15,188. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,925
Previous 1,035 85.99%
Holding current value
$15,188
Previous $9,000 55.56%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024
BUY
$7.26 - $10.7 $6,461 - $9,523
890 Added 85.99%
1,925 $14,000
Q2 2024

Jul 22, 2024
SELL
$7.63 - $12.66 $16,717 - $27,738
-2,191 Reduced 67.92%
1,035 $9,000
Q1 2024

Apr 23, 2024
BUY
$8.6 - $11.9 $5,813 - $8,044
676 Added 26.51%
3,226 $32,000
Q4 2023

Jan 19, 2024
SELL
$7.76 - $10.29 $10,794 - $14,313
-1,391 Reduced 35.3%
2,550 $25,000
Q3 2023

Oct 31, 2023
BUY
$9.14 - $24.62 $14,742 - $39,712
1,613 Added 69.29%
3,941 $36,000
Q2 2023

Jul 25, 2023
BUY
$23.2 - $27.29 $3,688 - $4,339
159 Added 7.33%
2,328 $57,000
Q1 2023

Apr 24, 2023
BUY
$22.26 - $30.85 $23,818 - $33,009
1,070 Added 97.36%
2,169 $50,000
Q4 2022

Jan 25, 2023
SELL
$19.96 - $28.22 $359 - $507
-18 Reduced 1.61%
1,099 $0
Q3 2022

Oct 25, 2022
BUY
$18.26 - $31.1 $164 - $279
9 Added 0.81%
1,117 $22,000
Q2 2022

Aug 04, 2022
BUY
$19.08 - $26.7 $2,060 - $2,883
108 Added 10.8%
1,108 $28,000
Q1 2022

Apr 19, 2022
BUY
$21.19 - $40.01 $7,946 - $15,003
375 Added 60.0%
1,000 $26,000
Q1 2021

May 07, 2021
SELL
$26.34 - $83.07 $16,462 - $51,918
-625 Reduced 50.0%
625 $32,000
Q3 2020

Nov 09, 2020
BUY
$28.28 - $53.6 $14,140 - $26,800
500 Added 66.67%
1,250 $43,000
Q2 2020

Aug 05, 2020
BUY
$27.89 - $47.86 $20,917 - $35,895
750 New
750 $31,000

Others Institutions Holding VIR

# of Institutions
216
Shares Held
86.7M
Call Options Held
127K
Put Options Held
1.19M
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $1.05B
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email